NeoBiocon is one of the leading UAE’s pharmaceutical company focused on innovation to deliver affordable healthcare solutions to patients, partners and healthcare systems across the GCC. NeoBiocon focuses on unmet medical needs and offers novel therapies with affordable prices to the patients. Today we market more than 20 products in various therapeutic categories and ranked amongst top 20 Pharmaceutical companies of the UAE. NeoBiocon brings innovative and affordable medicines for many of the world's most challenging diseases. Through our prescription medicines, we work with healthcare professionals to deliver innovative health solutions to their patients. With strong foot in cardiovascular segment, NeoBiocon is No.1 generic company in the cardiovascular market of the UAE. The company has also solid presence in other segments like Diabetes, Oncology, anti- infectives, asthma & allergy management & gastric disorders to name a few. We also demonstrate our commitment to increasing access to healthcare through far-reaching programs and partnerships.
| Website | http://www.biocon.com |
| Revenue | $1.7 billion |
| Employees | 32 (17 on RocketReach) |
| Founded | 2009 |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Healthcare, Innovation, Health Solutions, Patient Care, Biotechnology, Affordable Medicine, Drug Discovery, Medical Research, Therapeutics, Drug Development, Pharmaceutical Manufacturing, Novel Therapies, Biologics, Biosimilars, Clinical Trials, Generic Drugs |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, AstraZeneca, Novartis, Gilead Sciences, Sanofi, Merck AH, Lilly India +44 more (view full list) |
Looking for a particular NeoBiocon employee's phone or email?
The NeoBiocon annual revenue was $1.7 billion in 2026.
17 people are employed at NeoBiocon.